Our work with pharmaceutical and life sciences companies

A summary of our guiding principles

• We are open and transparent about our partnerships with the industry and our pharmaceutical and life sciences policy provides clear guidance on how we work with companies in this sector. This policy is reviewed yearly by the board of trustees.

• We have no preference for working with any one company, and welcome funding from multiple companies where practical and appropriate. 

• We do not accept pharmaceutical funding or donations for our policy and campaigns work. Where necessary, we will campaign against pharmaceutical companies on issues regarding access to drugs, in the interests of breast cancer patients, regardless of whether Breast Cancer Now is currently receiving funding or has historically received funding from a specific company. 

• We have agreements in place for each partnership and limits on donations as a percentage of our annual income.

Support in the latest financial year

We thank the following companies for providing donations and sponsorship, during our financial year August 2024 – July 2025, that amounted to £296,814

• Gilead Sciences Ltd
• Lilly UK
• Novartis Pharmaceuticals UK Limited
• Pfizer Limited
• Pierre Fabre Limited 
• Roche Products Ltd